Market Cap 1.89B
Revenue (ttm) 219.86M
Net Income (ttm) 44.04M
EPS (ttm) N/A
PE Ratio 43.31
Forward PE 39.59
Profit Margin 20.03%
Debt to Equity Ratio 0.00
Volume 73,200
Avg Vol 177,210
Day's Range N/A - N/A
Shares Out 22.59M
Stochastic %K 42%
Beta 0.82
Analysts Sell
Price Target $102.57

Company Profile

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temp...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 781 221 2266
Fax: 781 221 2223
Address:
63 Second Avenue, Burlington, United States
Estimize
Estimize Jul. 2 at 8:00 PM
Wall St is expecting 0.57 EPS for $LMAT Q2 [Reporting 07/24 AMC] http://www.estimize.com/intro/lmat?chart=historical&metric_name=eps&utm_co
0 · Reply
TalkMarkets
TalkMarkets Jun. 22 at 8:55 PM
Big Beautiful (Bill) Noise, Same Strategy - May Dividend Income Report $HD $DLMAF $LMAT $AAPL $MSFT https://talkmarkets.com/content/etfs/big-beautiful-bill-noise-same-strategy-may-dividend-income-report?post=505188
0 · Reply
Estimize
Estimize Jun. 19 at 12:03 PM
Wall St is expecting 0.57 EPS for $LMAT Q2 [Reporting 07/24 AMC] http://www.estimize.com/intro/lmat?chart=historical&metric_name=eps&utm_co
0 · Reply
Tyka
Tyka Jun. 18 at 1:16 PM
$LMAT $VOX and ? Why you telling us in public
0 · Reply
swingingtech
swingingtech Jun. 12 at 1:07 PM
$SDVY $LMAT $WHD $LZB https://wallstreetwaves.com/peek-under-the-hood-sdvy-has-12-upside/
0 · Reply
katiemcdaniels96
katiemcdaniels96 Jun. 11 at 1:54 PM
Hubby's Roth contribution went to $LMAT and started a position in $VOX with fractional purchase.
0 · Reply
DobroHoser
DobroHoser Jun. 3 at 12:23 PM
$LMAT I've been following this company for a while and just bought into an initial position. It's a strong company and last quarter the revenue up 12% and EPS was up 9% (and actually have been increasing over time). But what's interesting to me is the technical charting aspect at the moment. Sort of a triple bottom (or a triangle) setting up. I'm okay with holding onto this long term for it's growth dividend potential but would like to know if anyone else is following this company.
0 · Reply
DiamondCapital
DiamondCapital May. 23 at 2:43 PM
$ADHC GlucoGuard partnership with Dexcom (NASDAQ: $DXCM), a giant industry leader trading at a $33B market cap https://x.com/stockpicksnyc/status/1925924845025394752?s=46 Here’s GlucoGuard summary where Dexcom $DXCM is listed as the CGM developer glucoguardsleep.com/summary/ Also Bill Colone is on the ADHC/GlucoGuard team, he has an insane track record in the medical device field. He’s actually listed as Chairman of advisory board on the GlucoGuard website. Bill Colone is also the current CEO of SinglePass which recently got FDA clearance for their Kronos biopsy closure device last year. Bill actually navigated numerous companies through the FDA Approval process Bill Colone also helped position a surgical vascular graft product company IMPRA Inc which later was ACQUIRED by CR Bard for $143M Bill was Director of Operations of IMPRA for 11 years. Also Bill was the active CEO of Endomed when it was ACQUIRED by $LMAT LeMaitre Vascular, a $1.8B dollar company
0 · Reply
Neverquit888
Neverquit888 May. 7 at 2:08 AM
0 · Reply
DiamondCapital
DiamondCapital May. 1 at 3:39 PM
$ADHC is one to take serious. Bill Colone is actually listed as the Chairman of the Advisory Board for GlucoGuard His past companies he was involved in: •IMPRA Inc acquired by CR Bard for $143M •Endomed acquired by $LMAT LeMaitre Vascular •Bill Colone is also the current CEO of SinglePass which recently got FDA clearance for their Kronos biopsy closure device last year. Now he’s listed as the Chairman of the advisory board $ADHC GlucoGuard here: glucoguardsleep.com/about-us/ Bill joined ADHC last summer, here’s a link to the PR: https://www.newsfilecorp.com/release/211813/American-Diversified-Holdings-Corporation-ADHC-Retains-Bio-Device-Veteran-Bill-Colone-to-Advise-on-Entering-585-Billion-Bio-Device-Arena He had success and experience in the bio medical device field for over 30 years and he holds 13 US patents for medical devices with others pending. See more DD on ADHC here: https://x.com/stockpicksnyc/status/1917966445662683448?s=46
0 · Reply
Latest News on LMAT
Don't Be Too Cute, Buy These 3 Dividend Growers Instead

Jun 29, 2025, 7:00 AM EDT - 16 days ago

Don't Be Too Cute, Buy These 3 Dividend Growers Instead

BAM CMS


LeMaitre Vascular: Scaling Nicely As Global Demand Builds

Jun 17, 2025, 7:55 AM EDT - 4 weeks ago

LeMaitre Vascular: Scaling Nicely As Global Demand Builds


LeMaitre Vascular, Inc. (LMAT) Q1 2025 Earnings Call Transcript

May 1, 2025, 11:17 PM EDT - 2 months ago

LeMaitre Vascular, Inc. (LMAT) Q1 2025 Earnings Call Transcript


LeMaitre Q1 2025 Financial Results

May 1, 2025, 4:05 PM EDT - 2 months ago

LeMaitre Q1 2025 Financial Results


LeMaitre Vascular, Inc. (LMAT) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 11:16 PM EST - 4 months ago

LeMaitre Vascular, Inc. (LMAT) Q4 2024 Earnings Call Transcript


LeMaitre Q4 2024 Financial Results

Feb 27, 2025, 4:05 PM EST - 4 months ago

LeMaitre Q4 2024 Financial Results


Julie Biel shares her 2025 small cap picks

Dec 26, 2024, 6:32 PM EST - 7 months ago

Julie Biel shares her 2025 small cap picks

NCNO OLLI


Final Trade: LMAT, GOOGL, IBM, GILD

Dec 10, 2024, 6:50 PM EST - 7 months ago

Final Trade: LMAT, GOOGL, IBM, GILD

GOOG GOOGL IBM GILD


LeMaitre Vascular, Inc. (LMAT) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 7:59 PM EDT - 9 months ago

LeMaitre Vascular, Inc. (LMAT) Q3 2024 Earnings Call Transcript


LeMaitre Q3 2024 Financial Results

Oct 31, 2024, 4:05 PM EDT - 9 months ago

LeMaitre Q3 2024 Financial Results


LeMaitre Q2 2024 Financial Results

Aug 1, 2024, 4:05 PM EDT - 1 year ago

LeMaitre Q2 2024 Financial Results


LeMaitre Vascular: A Small Cap With Best-In-Industry Growth

Jul 23, 2024, 4:49 AM EDT - 1 year ago

LeMaitre Vascular: A Small Cap With Best-In-Industry Growth


LeMaitre Q1 2024 Financial Results

May 2, 2024, 4:05 PM EDT - 1 year ago

LeMaitre Q1 2024 Financial Results


LeMaitre Vascular, Inc. (LMAT) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 10:59 PM EST - 1 year ago

LeMaitre Vascular, Inc. (LMAT) Q4 2023 Earnings Call Transcript


LeMaitre Q4 2023 Financial Results

Feb 27, 2024, 4:05 PM EST - 1 year ago

LeMaitre Q4 2023 Financial Results


LeMaitre Q3 2023 Financial Results

Nov 1, 2023, 4:05 PM EDT - 1 year ago

LeMaitre Q3 2023 Financial Results


Estimize
Estimize Jul. 2 at 8:00 PM
Wall St is expecting 0.57 EPS for $LMAT Q2 [Reporting 07/24 AMC] http://www.estimize.com/intro/lmat?chart=historical&metric_name=eps&utm_co
0 · Reply
TalkMarkets
TalkMarkets Jun. 22 at 8:55 PM
Big Beautiful (Bill) Noise, Same Strategy - May Dividend Income Report $HD $DLMAF $LMAT $AAPL $MSFT https://talkmarkets.com/content/etfs/big-beautiful-bill-noise-same-strategy-may-dividend-income-report?post=505188
0 · Reply
Estimize
Estimize Jun. 19 at 12:03 PM
Wall St is expecting 0.57 EPS for $LMAT Q2 [Reporting 07/24 AMC] http://www.estimize.com/intro/lmat?chart=historical&metric_name=eps&utm_co
0 · Reply
Tyka
Tyka Jun. 18 at 1:16 PM
$LMAT $VOX and ? Why you telling us in public
0 · Reply
swingingtech
swingingtech Jun. 12 at 1:07 PM
$SDVY $LMAT $WHD $LZB https://wallstreetwaves.com/peek-under-the-hood-sdvy-has-12-upside/
0 · Reply
katiemcdaniels96
katiemcdaniels96 Jun. 11 at 1:54 PM
Hubby's Roth contribution went to $LMAT and started a position in $VOX with fractional purchase.
0 · Reply
DobroHoser
DobroHoser Jun. 3 at 12:23 PM
$LMAT I've been following this company for a while and just bought into an initial position. It's a strong company and last quarter the revenue up 12% and EPS was up 9% (and actually have been increasing over time). But what's interesting to me is the technical charting aspect at the moment. Sort of a triple bottom (or a triangle) setting up. I'm okay with holding onto this long term for it's growth dividend potential but would like to know if anyone else is following this company.
0 · Reply
DiamondCapital
DiamondCapital May. 23 at 2:43 PM
$ADHC GlucoGuard partnership with Dexcom (NASDAQ: $DXCM), a giant industry leader trading at a $33B market cap https://x.com/stockpicksnyc/status/1925924845025394752?s=46 Here’s GlucoGuard summary where Dexcom $DXCM is listed as the CGM developer glucoguardsleep.com/summary/ Also Bill Colone is on the ADHC/GlucoGuard team, he has an insane track record in the medical device field. He’s actually listed as Chairman of advisory board on the GlucoGuard website. Bill Colone is also the current CEO of SinglePass which recently got FDA clearance for their Kronos biopsy closure device last year. Bill actually navigated numerous companies through the FDA Approval process Bill Colone also helped position a surgical vascular graft product company IMPRA Inc which later was ACQUIRED by CR Bard for $143M Bill was Director of Operations of IMPRA for 11 years. Also Bill was the active CEO of Endomed when it was ACQUIRED by $LMAT LeMaitre Vascular, a $1.8B dollar company
0 · Reply
Neverquit888
Neverquit888 May. 7 at 2:08 AM
0 · Reply
DiamondCapital
DiamondCapital May. 1 at 3:39 PM
$ADHC is one to take serious. Bill Colone is actually listed as the Chairman of the Advisory Board for GlucoGuard His past companies he was involved in: •IMPRA Inc acquired by CR Bard for $143M •Endomed acquired by $LMAT LeMaitre Vascular •Bill Colone is also the current CEO of SinglePass which recently got FDA clearance for their Kronos biopsy closure device last year. Now he’s listed as the Chairman of the advisory board $ADHC GlucoGuard here: glucoguardsleep.com/about-us/ Bill joined ADHC last summer, here’s a link to the PR: https://www.newsfilecorp.com/release/211813/American-Diversified-Holdings-Corporation-ADHC-Retains-Bio-Device-Veteran-Bill-Colone-to-Advise-on-Entering-585-Billion-Bio-Device-Arena He had success and experience in the bio medical device field for over 30 years and he holds 13 US patents for medical devices with others pending. See more DD on ADHC here: https://x.com/stockpicksnyc/status/1917966445662683448?s=46
0 · Reply
DiamondCapital
DiamondCapital Apr. 30 at 3:57 PM
$ADHC GlucoGuard partnered is with a $28 billion dollar company, Dexcom. Mentioned in 10/29 PR Here’s GlucoGuard summary where Dexcom $DXCM is listed as the CGM developer glucoguardsleep.com/summary/ Also Bill Colone is on the ADHC/GlucoGuard team, he has an insane track record in the medical device field. He’s actually listed as Chairman of advisory board on the GlucoGuard site Bill Colone is also the current CEO of SinglePass which got FDA clearance for their Kronos biopsy closure device last year And Bill Colone helped position a surgical vascular graft product company IMPRA Inc which later was ACQUIRED by CR Bard for $143M Also Bill was the active CEO of Endomed when it was ACQUIRED by $LMAT LeMaitre Vascular It’s crazy to see veterans this caliber on the team of a OTC company. Both Bill Colone and Stephen C. Weber are listed on the team on the GlucoGuard website here: glucoguardsleep.com/about-us/ DD thread here: https://x.com/stockpicksnyc/status/1917608046857183439?s=46
0 · Reply
History101
History101 Apr. 23 at 6:51 PM
$LMAT LMAT could buy $ELTP...GLTALs!!
0 · Reply
History101
History101 Apr. 23 at 6:49 PM
$LMAT 505 watching 4/23/2025
0 · Reply
stklover
stklover Apr. 22 at 10:33 PM
$LMAT Jim Cramer just touted the stock. So I’ll short it tomorrow.
0 · Reply
PennyWiseCalls
PennyWiseCalls Apr. 22 at 10:31 PM
$LMAT leg up from here $100🎁✅
0 · Reply
TalkMarkets
TalkMarkets Apr. 3 at 9:38 PM
Small-Cap Dividend Stocks: Hidden Gems Or High-Risk Plays? $ACU $LMAT $OTCM $YORW https://talkmarkets.com/content/us-markets/small-cap-dividend-stocks-hidden-gems-or-high-risk-plays?post=489993
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 26 at 10:08 PM
$LMAT Digging LMAT's strategic moves in vascular devices. Solid growth trajectory with 14% rev bump in 2024. International expansion looking sharp, esp Asia Pacific play. Watching closely for Q1 2025 performance. Could be a steady performer in medtech space. compelling article: https://beyondspx.com/article/lemaitre-vascular-lmat-a-steady-hand-navigating-the-vascular-device-market
0 · Reply
Bravosatya
Bravosatya Mar. 10 at 10:37 PM
$SRTS guys other stocks are now cheaper. I am focusing on $ARCB , $PCOR , $ATR and $LMAT
2 · Reply
swingingtech
swingingtech Mar. 4 at 5:04 PM
$OPCH $LMAT https://wallstreetwaves.com/best-momentum-stocks-to-buy-for-march-4th/
0 · Reply
IN0V8
IN0V8 Feb. 28 at 6:51 PM
$LMAT Barrington Research cuts to market perform from outperform Jefferies raises target price to $90 from $85 Oppenheimer cuts to perform from outperform Stifel raises target price to $115 from $100
0 · Reply
JarvisFlow
JarvisFlow Feb. 28 at 5:02 PM
Lake Street has updated their rating for LeMaitre Vascular ( $LMAT ) to Buy with a price target of 110.
0 · Reply
JarvisFlow
JarvisFlow Feb. 28 at 3:55 PM
Citizens Capital Markets updates rating for LeMaitre Vascular ( $LMAT ) to Buy, target set at 105 → 110.
0 · Reply